Le Lézard
Classified in: Health
Subject: ATY

SPRO LAWSUIT ALERT: Levi & Korsinsky Notifies Spero Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline


NEW YORK, July 7, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Spero Therapeutics, Inc. ("Spero" or the "Company") (NASDAQ: SPRO) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Spero investors who were adversely affected by alleged securities fraud between October 28, 2021 and May 2, 2022. Follow the link below to get more information and be contacted by a member of our team:

https://www.zlk.com/pslra-1/spero-therapeutics-inc-loss-submission-
form?prid=29564&wire=4

SPRO investors may also contact Joseph E. Levi, Esq. via email
at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) the data submitted in support of the New Drug Application ("NDA") for the Company's product candidate, Tebipenem HBr, were insufficient to obtain  approval from the U.S. Food and Drug Administration ("FDA"); (ii) accordingly, it was unlikely that the FDA would approve the Tebipenem HBr NDA in its current form; (iii) the foregoing would necessitate a significant workforce reduction and restructuring of Spero's operations; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

WHAT'S NEXT? If you suffered a loss in Spero during the relevant time frame, you have until July 25, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP


These press releases may also interest you

at 12:12
Bioidentical hormone replacement therapy (BHRT) helps restore your natural hormone levels to what they were when you were younger. Anyone who experiences symptoms that might be related to hormone imbalance is a candidate for BHRT, including...

at 12:08
Total Testing Solutions (TTS), a Los Angeles-based medical diagnostic testing company has announced a partnership with private lab, OmniPathology to offer oral HPV testing in the LA area. This state-of-the-art testing is now available at the West LA...

at 12:05
Phytocann Group, a vertically integrated company and European CBD pioneer, is proud to announce a partnership with Pharmasimple, a company listed on Euronext Growth Paris and industry leader in Belgium. This strategic rapprochement opens up a new era...

at 12:00
Roundstone, a health insurance provider specializing in self-funded medical group captive solutions for small and mid-sized companies, has been named one of the fastest-growing private companies in America by Inc. 5000 for the fifth consecutive year....

at 12:00
New York Bariatric Group (NYBG), the nationally renowned bariatric practice with the country's most accomplished bariatric surgeons establishes NYBG Veins and opens 2 offices in Nassau and Westchester County, New York. Utilizing NYBG methodology of...

at 11:50
The team at The Driscoll Firm is proud to announce that they have secured a $299 million judgment against the Islamic Republic of Iran on behalf of families of U.S. service members wounded or killed in terrorist attacks in Iraq. The Driscoll Firm is...



News published on 7 july 2022 at 05:45 and distributed by: